pharm-stream-recent-webinars
-
How High Drug Load Nanocrystalline Tablets Lower Pill Burden
3/12/2025
We showcase the development of high drug load nanocrystal based tablets and prove that nanocrystals can match the pharmacokinetic performance of ASDs while reducing the overall pill burden.
-
Human Factors Testing: Engaging End-Users In Med Device Development
3/11/2025
Explore the significance of human factors in the development of medical devices through an illustration of how important it is to incorporate the end users in the device development process.
-
Get $mart: 1 Year Out From Phase 1 Injectable Trials, Avoid 3 Expensive Mistakes
3/6/2025
Learn how to scale up injectable drug production for Phase 1 trials, avoid costly mistakes, and find the right CDMO partner for long-term success.
-
Bioprocess Optimization: Leveraging Functional DOE With Time-Based Insights
3/5/2025
Explore the key differences between traditional DOE and Functional DOE as Seongjin Kim demonstrates how the latter enhances bioprocess optimization through a fed-batch cell culture example.
-
Digital Enhancements For Operational Excellence
2/20/2025
Unlock operational excellence with digital enhancements. Discover practical strategies to reduce errors, streamline processes, and drive continuous improvement across industries.
-
De-Risking Early Phase Micronization With Integrated Solid Form Selection
2/18/2025
Review the crucial selection of the optimal solid form in carefully achieving successful jet milling of APIs designed specifically for pulmonary administration through the pulmonary route.
-
Efficient Downstream Processing Of Antibody-Based Therapeutics – A CDMO Perspective
2/18/2025
Discover efficient downstream processing strategies for antibody-based therapeutics. Explore key considerations and trade-offs in purity, yield, speed, and cost, from a CDMO perspective.
-
Contract Manufacturing: Must-Know Trends And Strategies For 2025
2/12/2025
Regulated industries face rising demand, tech breakthroughs, and regulatory harmonization. Discover how contract manufacturers must leverage AI and cloud solutions to stay agile and compliant in the future.
-
CMC And Clinical Strategies For Developing Injectable, Oral Peptide Drugs
2/6/2025
In this session, Chief Scientific Officer Dr. Andy Lewis delves into the key drivers shaping peptide drug development and explores innovative delivery options to enhance therapeutic outcomes.
-
The Next Frontier In mRNA: Modular Manufacturing For Scalable RNA-LNP Therapies
1/29/2025
Explore constructing a modular RNA-LNP GMP facility using Cytiva's FlexFactory™ process train in a KUBio™ environment to scale RNA-LNP therapies.